Trial · NCT03298451
Results by group96
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 96
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Overall Survival (OS) - Treme 300 mg x1 Dose + Durva 1500 mg vs Sora 400 mg | Durva 1500 mg | 16.56 | 95% Confidence Interval 14.06 to 19.12 | months | |
| Overall Survival (OS) - Treme 300 mg x1 Dose + Durva 1500 mg vs Sora 400 mg | Treme 300 mg x1 Dose + Durva 1500 mg | 16.43 | 95% Confidence Interval 14.16 to 19.58 | months | |
| Overall Survival (OS) - Treme 300 mg x1 Dose + Durva 1500 mg vs Sora 400 mg | Treme 75 mg x4 Doses + Durva 1500 mg | 16.36 | 95% Confidence Interval 12.39 to 19.65 | months | |
| Overall Survival (OS) - Treme 300 mg x1 Dose + Durva 1500 mg vs Sora 400 mg | Sora 400 mg | 13.77 | 95% Confidence Interval 12.25 to 16.13 | months | |
| Overall Survival (OS) - Durva 1500 mg vs Sora 400 mg | Durva 1500 mg | 16.56 | 95% Confidence Interval 14.06 to 19.12 | months | |
| Overall Survival (OS) - Durva 1500 mg vs Sora 400 mg | Treme 300 mg x1 Dose + Durva 1500 mg | 16.43 | 95% Confidence Interval 14.16 to 19.58 | months | |
| Overall Survival (OS) - Durva 1500 mg vs Sora 400 mg | Treme 75 mg x4 Doses + Durva 1500 mg | 16.36 | 95% Confidence Interval 12.39 to 19.65 | months | |
| Overall Survival (OS) - Durva 1500 mg vs Sora 400 mg | Sora 400 mg | 13.77 | 95% Confidence Interval 12.25 to 16.13 | months | |
| Overall Survival (OS) at 18, 24, and 36 Months After Randomization | Durva 1500 mg | Survival rate at 18 months | 47.4 | 95% Confidence Interval 42.4 to 52.3 | percentage of survival |
| Overall Survival (OS) at 18, 24, and 36 Months After Randomization | Treme 300 mg x1 Dose + Durva 1500 mg | Survival rate at 18 months | 48.7 | 95% Confidence Interval 43.6 to 53.5 | percentage of survival |
| Overall Survival (OS) at 18, 24, and 36 Months After Randomization | Treme 75 mg x4 Doses + Durva 1500 mg | Survival rate at 18 months | 46.4 | 95% Confidence Interval 38.4 to 54.1 | percentage of survival |
| Overall Survival (OS) at 18, 24, and 36 Months After Randomization | Sora 400 mg | Survival rate at 18 months | 41.5 | 95% Confidence Interval 36.5 to 46.4 | percentage of survival |
| Overall Survival (OS) at 18, 24, and 36 Months After Randomization | Durva 1500 mg | Survival rate at 24 months | 39.6 | 95% Confidence Interval 34.8 to 44.5 | percentage of survival |
| Overall Survival (OS) at 18, 24, and 36 Months After Randomization | Treme 300 mg x1 Dose + Durva 1500 mg | Survival rate at 24 months | 40.5 | 95% Confidence Interval 35.6 to 45.3 | percentage of survival |
| Overall Survival (OS) at 18, 24, and 36 Months After Randomization | Treme 75 mg x4 Doses + Durva 1500 mg | Survival rate at 24 months | 37.3 | 95% Confidence Interval 29.6 to 44.9 | percentage of survival |
| Overall Survival (OS) at 18, 24, and 36 Months After Randomization | Sora 400 mg | Survival rate at 24 months | 32.6 | 95% Confidence Interval 27.9 to 37.4 | percentage of survival |
| Overall Survival (OS) at 18, 24, and 36 Months After Randomization | Durva 1500 mg | Survival rate at 36 months | 24.7 | 95% Confidence Interval 20.0 to 29.8 | percentage of survival |
| Overall Survival (OS) at 18, 24, and 36 Months After Randomization | Treme 300 mg x1 Dose + Durva 1500 mg | Survival rate at 36 months | 30.7 | 95% Confidence Interval 25.8 to 35.7 | percentage of survival |
| Overall Survival (OS) at 18, 24, and 36 Months After Randomization | Treme 75 mg x4 Doses + Durva 1500 mg | Survival rate at 36 months | 22.9 | 95% Confidence Interval 16.6 to 29.8 | percentage of survival |
| Overall Survival (OS) at 18, 24, and 36 Months After Randomization | Sora 400 mg | Survival rate at 36 months | 20.2 | 95% Confidence Interval 15.8 to 25.1 | percentage of survival |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03298451/results